Current advances in the study of diabetic cardiomyopathy: From clinicopathological features to molecular therapeutics (Review)

Mol Med Rep. 2019 Sep;20(3):2051-2062. doi: 10.3892/mmr.2019.10473. Epub 2019 Jul 4.

Abstract

The incidence of diabetes mellitus has become a major public health concern due to lifestyle alterations. Moreover, the complications associated with diabetes mellitus deeply influence the quality of life of patients. Diabetic cardiomyopathy (DC) is a type of diabetes mellitus complication characterized by functional and structural damage in the myocardium but not accompanied by coronary arterial disease. Currently, diagnosing and preventing DC is still a challenge for physicians due to its atypical symptoms. For this reason, it is necessary to summarize the current knowledge on DC, especially in regards to the underlying molecular mechanisms toward the goal of developing useful diagnostic approaches and effective drugs based on these mechanisms. There exist several review articles which have focused on these points, but there still remains a lot to learn from published studies. In this review, the features, diagnosis and molecular mechanisms of DC are reviewed. Furthermore, potential therapeutic and prophylactic drugs are discussed.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Cardiac Catheterization
  • Coronary Angiography
  • Diabetic Cardiomyopathies / diagnosis*
  • Diabetic Cardiomyopathies / drug therapy
  • Diabetic Cardiomyopathies / metabolism
  • Diabetic Cardiomyopathies / pathology*
  • Echocardiography
  • Humans
  • Magnetic Resonance Imaging
  • Molecular Targeted Therapy
  • Myocardium / metabolism
  • Myocardium / pathology*
  • Signal Transduction / drug effects

Substances

  • Biomarkers